Quality 2030: quality inside Quality 2030: quality inside

By 2030, Quality in Life Sciences will transform from a compliance necessity to a catalyst for amplifying value. By infusing quality throughout the enterprise, organizations can create offerings that are more closely aligned with customer needs, lower compliance risk, and fuel continuous improvement. There are so many opportunities for quality to become a competitive advantage that Quality transformation should be on the boardroom agenda for years to come. How can CXOs take their organizations there? By bringing quality inside.

The journey of bringing quality inside rests on three key pillars:

1. Technology and innovation: 80% of Life Sciences CEOs expect to see a return on investment from AI, robotic process automation and digital technologies in the next 1-3 according to KPMG's 2019 Global CEO Outlook survey.
2. Operating model: To transform Quality, CXO's should consider how the entire Life Sciences operating model needs to shift, such that quality is infused across the organization.
3. Talent and culture: Leadership will need to advance a quality mindset throughout the enterprise, empower teams to manage the change, and ensure that quality efforts are aligned with the value chain.

Download the full report to learn more about how your organization can better prepare itself to bring quality inside.